Group 6 Copy 70
1
Please wait...

About This Project

In 2011, scientists developed a unique class of antivirals named DRACOs. DRACO proteins kill cells that are infected with viruses. One limitation to this technology is that DRACO proteins would also kill cells infected with benign viruses. Humans are often infected with benign viruses. We have modified DRACOs to specifically target cells infected with a disease-causing virus without harming regular cells. This novel strategy could be used more broadly against other disease-causing viruses.

Blast off!

Browse Other Projects on Experiment

Related Projects

Why do wolverines need snow?

A warming climate in the Arctic is having profound impacts on species that rely on snow and ice, like the polar...

How do we keep wild rhino populations growing during a poaching crisis? The final countdown

African rhinos are of great economic and ecological importance within their range states,but are threatened...

Campaign Ended

A biology project funded by 18 people